Meredith S. Manning
Corporate Officer/Principal at SOLENO THERAPEUTICS, INC.
Profile
Meredith S.
Manning is currently the Chief Commercial Officer at Soleno Therapeutics, Inc. She previously worked as the Vice President-Global Hemophilia Marketing at Baxter International, Inc. from 2013 to 2015.
She was also the President-Americas at PharmaEssentia Corp.
and the Chief Commercial Officer at resTORbio, Inc. from 2018 to 2019.
Ms. Manning received her undergraduate degree from The Colorado College and her MBA from The University of Chicago Booth School of Business.
Meredith S. Manning active positions
| Companies | Position | Start |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-01-23 |
Former positions of Meredith S. Manning
| Companies | Position | End |
|---|---|---|
| ADICET BIO, INC. | Corporate Officer/Principal | 2019-12-05 |
| BAXTER INTERNATIONAL INC. | Sales & Marketing | 2015-06-30 |
| PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - |
Training of Meredith S. Manning
| The Colorado College | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| PHARMAESSENTIA CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Meredith S. Manning
